
Rapt Therapeutics, Actelis Networks, and Firefly Neuroscience are the three Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—generally roughly $300 million to $2 billion, though exact cutoffs vary by index or fund provider. They often offer higher growth potential but come with greater volatility, lower liquidity, and more company-specific risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Rapt Therapeutics (RAPT)
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Actelis Networks (ASNS)
Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications.
Read Our Latest Research Report on ASNS
Firefly Neuroscience (AIFF)
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
Read Our Latest Research Report on AIFF
Read More
- MarketBeat’s Top Five Stocks to Own in March 2026
- Solar Flare: A Perfect Storm for Solar Stocks
- The $650 Billion AI Surge Is Here—2 Semiconductor ETFs to Play It
- Target’s 2026 Turnaround: Analysts Bullish as Growth Returns
- Vertiv: A Market Breather for an AI Infrastructure Leader
- Tesla’s 2026 May Hinge on a March 9 Outcome
